The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Open accessAbstract
Abnormal accumulation of proteinaceous intraneuronal inclusions called Lewy bodies (LBs) is the neurpathological hallmark of Parkinson’s disease (PD) and related synucleinopathies. These inclusions are mainly constituted of a presynaptic protein, α-synuclein ( α-syn). Over the past decade, growing amounts of studies reported an aberrant accumulation of phosphorylated α-syn at the residue S129 (pS129) in the brain of patients suffering from PD, as well as in transgenic animal models of synucleinopathies. Whereas only a small fraction of α-syn (<4%) is phosphorylated in healthy brains, a dramatic accumulation of pS129 (>90%) has been observed within LBs, suggesting that this post-translational modification may play an important role in the regulation of α-syn aggregation, LBs formation and neuronal degeneration. However, whether phosphorylation at S129 suppresses or enhances α-syn aggregation and toxicity in vivo remains a subject of active debate. The answer to this question has important implications for understanding the role of phosphorylation in the pathogenesis of synucleinopathies and determining if targeting kinases or phosphatases could be a viable therapeutic strategy for the treatment of these devastating neurological disorders. In the present review, we explore recent findings from in vitro, cell-based assays and in vivo studies describing the potential implications of pS129 in the regulation of α-syn physiological functions, as well as its implication in synucleinopathies pathogenesis and diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Seo, J., Rah, J., Choi, S. H., Shin, J. K., Min, K., Kim, H., Park, C. H., Kim, S., Kim, E., Lee, S., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0041fje · Cited by 208
RetractedUbiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
Lonskaya, I., Desforges, N. M., Hebron, M. L., & Moussa, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083914 · Cited by 89
RetractedEffect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes
Visanji, N. P., Wislet‐Gendebien, S., Oschipok, L. W., Zhang, G., Aubert, I., Fraser, P. E., & Tandon, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253450 · Cited by 62
RetractedSpillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,812
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Self-citationVolpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,416
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Structure and Dynamics of Micelle-bound Human α-Synuclein
Ulmer, T. S., Bax, A., Cole, N. B., & Nussbaum, R. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411805200 · Cited by 966
Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 938
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879
Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M., & Dobson, C. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044834j · Cited by 716
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150642 · Cited by 573
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 519
Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.026 · Cited by 479
Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions
Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V. M.-Y., Trojanowski, J. Q., Mann, D., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208046200 · Cited by 428
Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases
Pronin, A. N., Morris, A. J., Surguchov, A., & Benovic, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003542200 · Cited by 387
Binolfi, A., Rasia, R. M., Bertoncini, C. W., Ceolin, M., Zweckstetter, M., Griesinger, C., Jovin, T. M., & Fernández, C. O. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0618649 · Cited by 387
Jensen, P. H., Hager, H., Nielsen, M. S., Højrup, P., Gliemann, J., & Jakes, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25481 · Cited by 377
McCann, H., Stevens, C. H., Cartwright, H., & Halliday, G. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70017-8 · Cited by 364
Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H.-Y., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Fernandez, C. O., Eliezer, D., Zweckstetter, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800747200 · Cited by 363
Hoyer, W., Cherny, D., Subramaniam, V., & Jovin, T. M. (2004) · Biochemistry · doi:10.1021/bi048453u · Cited by 356
Neumann, M., Kahle, P. J., Giasson, B. I., Ozmen, L., Borroni, E., Spooren, W., Müller, V., Odoy, S., Fujiwara, H., Hasegawa, M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15777 · Cited by 355
Oueslati, A., Fournier, M., & Lashuel, H. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)83007-9 · Cited by 347
Self-citationHilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Hagan, H., & Carroll, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1214-6 · Cited by 345
Properties of native brain α-synuclein
Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A. T., & Südhof, T. C. (2013) · Nature · doi:10.1038/nature12125 · Cited by 339
Nuclear Localization of α-Synuclein and Its Interaction with Histones
Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi0341152 · Cited by 337
Copper(II)-induced self-oligomerization of α-synuclein
Paik, S. R., Shin, H.-J., Lee, J., Chang, C., & Kim, J. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400821 · Cited by 337
Hebron, M. L., Lonskaya, I., & Moussa, C. E. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt192 · Cited by 325
Gorbatyuk, O. S., Li, S., Sullivan, L. F., Chen, W., Kondrikova, G., Manfredsson, F. P., Mandel, R. J., & Muzyczka, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711053105 · Cited by 293
Skin nerve α-synuclein deposits: A biomarker for idiopathic Parkinson disease
Donadio, V., Incensi, A., Leta, V., Giannoccaro, M. P., Scaglione, C., Martinelli, P., Capellari, S., Avoni, P., Baruzzi, A., & Liguori, R. (2014) · Neurology · doi:10.1212/wnl.0000000000000316 · Cited by 290
Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway
Tofaris, G. K., Kim, H. T., Hourez, R., Jung, J.-W., Kim, K. P., & Goldberg, A. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109356108 · Cited by 271
Yamada, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02728.x · Cited by 270
NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation
Fernández, C. O., Hoyer, W., Zweckstetter, M., Jares‐Erijman, E. A., Subramaniam, V., Griesinger, C., & Jovin, T. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600211 · Cited by 255
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081950 · Cited by 246
Self-citationFares, M.-B., Ait-Bouziad, N., Dikiy, I., Mbefo, M. K., Jovi i, A., Kiely, A., Holton, J. L., Lee, S.-J., Gitler, A. D., Eliezer, D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu165 · Cited by 241
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Inglis, K. J., Chereau, D., Brigham, E. F., Chiou, S.-S., Schöbel, S., Frigon, N. L., Yu, M., Caccavello, R. J., Nelson, S., Motter, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800206200 · Cited by 240
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
Doppler, K., Ebert, S., Üçeyler, N., Trenkwalder, C., Ebentheuer, J., Volkmann, J., & Sommer, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1284-0 · Cited by 238
Seeburg, D. P., Feliu-Mojer, M., Gaiottino, J., Pak, D. T. S., & Sheng, M. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.021 · Cited by 228
Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers
Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 226
Alpha-Synuclein Function and Dysfunction on Cellular Membranes
Snead, D., & Eliezer, D. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.292 · Cited by 223
Mahul-Mellier, A.-L., Fauvet, B., Gysbers, A., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A. J., Bisquertt, A., Eliezer, D., Masliah, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt674 · Cited by 219
Self-citationChen, L., Periquet, M., Wang, X., Negro, A., McLean, P. J., Hyman, B. T., & Feany, M. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39088 · Cited by 215
Chen, S., Grigsby, C. L., Law, C. S., Ni, X., Nekrep, N., Olsen, K., Humphreys, M. H., & Gardner, D. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35314 · Cited by 213
Structure and properties of α-synuclein and other amyloids determined at the amino acid level
Del Mar, C., Greenbaum, E. A., Mayne, L., Englander, S. W., & Woods, V. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507405102 · Cited by 209
Hashimoto, M., Hsu, L. J., Rockenstein, E., Takenouchi, T., Mallory, M., & Masliah, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111428200 · Cited by 205
Foulds, P. G., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P., Hasegawa, M., Taylor, M., Mann, D., & Allsop, D. (2011) · The FASEB Journal · doi:10.1096/fj.10-179192 · Cited by 205
Oueslati, A., Schneider, B. L., Aebischer, P., & Lashuel, H. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309991110 · Cited by 203
Self-citationFolding and misfolding of alpha-synuclein on membranes
Dikiy, I., & Eliezer, D. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.09.008 · Cited by 198
Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.028 · Cited by 194
Azeredo da Silveira, S., Schneider, B. L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M., & Aebischer, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn417 · Cited by 190
Biophysics of α-synuclein membrane interactions
Pfefferkorn, C. M., Jiang, Z., & Lee, J. C. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.032 · Cited by 189
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
Foulds, P. G., Diggle, P., Mitchell, J. D., Parker, A., Hasegawa, M., Masuda-Suzukake, M., Mann, D. M. A., & Allsop, D. (2013) · Scientific Reports · doi:10.1038/srep02540 · Cited by 185
Burré, J., Sharma, M., & Südhof, T. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3545-12.2012 · Cited by 178
Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions
McFarland, M. A., Ellis, C. E., Markey, S. P., & Nussbaum, R. L. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800116-mcp200 · Cited by 176
α-Synuclein fate is determined by USP9X-regulated monoubiquitination
Rott, R., Szargel, R., Haskin, J., Bandopadhyay, R., Lees, A. J., Shani, V., & Engelender, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105725108 · Cited by 174
Yap, T. L., Gruschus, J. M., Velayati, A., Westbroek, W., Goldin, E., Moaven, N., Sidransky, E., & Lee, J. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237859 · Cited by 174
Fauvet, B., Fares, M.-B., Samuel, F., Dikiy, I., Tandon, A., Eliezer, D., & Lashuel, H. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383711 · Cited by 169
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Qing, H., Wong, W., McGeer, E. G., & McGeer, P. L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.142 · Cited by 163
Walker, D. G., Lue, L., Adler, C. H., Shill, H. A., Caviness, J. N., Sabbagh, M. N., Akiyama, H., Serrano, G. E., Sue, L. I., & Beach, T. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.020 · Cited by 157
Haj‐Yahya, M., Fauvet, B., Herman-Bachinsky, Y., Hejjaoui, M., Bavikar, S. N., Karthikeyan, S. V., Ciechanover, A. J., Lashuel, H. A., & Brik, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315654110 · Cited by 156
Tenreiro, S., Reimão-Pinto, M. M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhães, F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004302 · Cited by 154
α-synuclein phosphorylation and truncation are normal events in the adult human brain
Muntané, G., Ferrer, I., & Martínez‐Vicente, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.042 · Cited by 153
Sato, H., Arawaka, S., Hara, S., Fukushima, S., Koga, K., Koyama, S., & Kato, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3967-11.2011 · Cited by 142
The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease
Arawaka, S., Wada, M., Goto, S., Karube, H., Sakamoto, M., Ren, C.-H., Koyama, S., Nagasawa, H., Kimura, H., Kawanami, T., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0341-06.2006 · Cited by 142
Machiya, Y., Hara, S., Arawaka, S., Fukushima, S., Sato, H., Sakamoto, M., Koyama, S., & Kato, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141952 · Cited by 137
McFarland, N. R., Fan, Z., Xu, K., Schwarzschild, M. A., Feany, M. Β., Hyman, B. T., & McLean, P. J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a24b53 · Cited by 136
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease
Zhou, J., Broe, M., Huang, Y. M., Anderson, J. P., Gai, W., Milward, E. A., Porritt, M. J., Howells, D. W., Hughes, A. J., Wang, X., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0815-1 · Cited by 135
Nuclear and neuritic distribution of serine-129 phosphorylated α-synuclein in transgenic mice
Schell, H., Hasegawa, T., Neumann, M., & Kahle, P. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.002 · Cited by 135
Jensen, P. H., Islam, K., Kenney, J. M., Nielsen, M. S., Power, J., & Gai, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000099200 · Cited by 134
Bertini, I., Gupta, Y. K., Luchinat, C., Parigi, G., Peana, M., Sgheri, L., & Yuan, J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0726613 · Cited by 133
Takahashi, M., Kanuka, H., Fujiwara, H., Koyama, A., Hasegawa, M., Miura, M., & Iwatsubo, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01258-2 · Cited by 129
Lu, Y., Prudent, M., Fauvet, B., Lashuel, H. A., & Girault, H. H. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200074d · Cited by 122
Wu, K., Kim, S., Fela, D. A., & Baum, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.017 · Cited by 122
Oueslati, A., Paleologou, K. E., Schneider, B. L., Aebischer, P., & Lashuel, H. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3784-11.2012 · Cited by 121
Self-citationKahle, P. J., Neumann, M., Ozmen, L., & Haass, C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06902.x · Cited by 119
Lou, H., Montoya, S. E., Alerte, T. N. M., Wang, J., Wu, J., Peng, X., Hong, C.-S., Friedrich, E. E., Mader, S. A., Pedersen, C. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100867 · Cited by 115
Foulds, P. G., Yokota, O., Thurston, A., Davidson, Y. S., Ahmed, Z., Holton, J. L., Thompson, J. C., Akiyama, H., Arai, T., Hasegawa, M., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.003 · Cited by 112
Chau, K., Ching, H. L., Schapira, A. H. V., & Cooper, J. A. D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06191.x · Cited by 106
Waudby, C. A., Camilloni, C., Fitzpatrick, A. W. P., Cabrita, L. D., Dobson, C. M., Vendruscolo, M., & Christodoulou, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072286 · Cited by 105
Swirski, M., Miners, J. S., de Silva, R., Lashley, T., Ling, H., Holton, J. L., Révész, T., & Love, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0077-y · Cited by 98
Assessing the Subcellular Dynamics of Alpha-synuclein Using Photoactivation Microscopy
Gonçalves, S. A., & Outeiro, T. F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8406-x · Cited by 97
Protein–protein interactions of alpha-synuclein in brain homogenates and transfected cells
Payton, J. E., Perrin, R. J., Clayton, D. F., & George, J. M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00257-1 · Cited by 95
Kuwahara, T., Tonegawa‐Kuji, R., Ito, G., Mitani, S., & Iwatsubo, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237131 · Cited by 91
Wakamatsu, M., Ishii, A., Ukai, Y., Sakagami, J., Iwata, S., Ono, M., Matsumoto, K., Nakamura, A., Tada, N., Kobayashi, K., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21310 · Cited by 91
α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner
Yin, G., da Fonseca, T. L., Eisbach, S. E., Anduaga, A. M., Breda, C., Orcellet, M. L., Szegő, É. M., Guerreiro, P. S., Lázaro, D. F., Braus, G. H., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.018 · Cited by 88
Cherny, D., Hoyer, W., Subramaniam, V., & Jovin, T. M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.096 · Cited by 85
Polo-like kinases in the nervous system
Seeburg, D. P., Pak, D. T. S., & Sheng, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208277 · Cited by 85
Interplay between Sumoylation and Phosphorylation for Protection against α-Synuclein Inclusions
Shahpasandzadeh, H., Popova, B., Kleinknecht, A., Fraser, P. E., Outeiro, T. F., & Braus, G. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559237 · Cited by 81
Bisaglia, M., Tessari, I., Mammi, S., & Bubacco, L. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8082-1 · Cited by 81
Generation of Ferric Iron Links Oxidative Stress to α-Synuclein Oligomer Formation
Levin, J., Högen, T., Hillmer, A. S., Bader, B., Schmidt, F., Kamp, F., Kretzschmar, H. A., Bötzel, K., & Giese, A. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11040 · Cited by 80
Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra
McCormack, A. L., Mak, S. K., & Monte, D. A. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.50 · Cited by 80
Zhou, R. M., Huang, Y., Li, X. L., Chen, C., Shi, Q., Wang, G. R., Tian, C., Wang, Z. Y., Jing, Y., Gao, C., et al. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9899-2 · Cited by 80
Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein
Waxman, E. A., & Giasson, B. I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22537 · Cited by 78
Polo-like kinases mediate cell survival in mitochondrial dysfunction
Matsumoto, T., Wang, P., Ma, W., Sung, H. J., Matoba, S., & Hwang, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904229106 · Cited by 76
Ma, K., Song, L.-K., Yuan, Y., Zhang, Y., Han, N., Gao, K., & Chen, N. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.035 · Cited by 73
Mbefo, M. K., Fares, M.-B., Paleologou, K. E., Oueslati, A., Yin, G., Tenreiro, S., Pinto, M. M. M., Outeiro, T. F., Zweckstetter, M., Masliah, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610774 · Cited by 70
Self-citationAlpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death
Monti, B., Polazzi, E., Batti, L., Crochemore, C., Virgili, M., & Contestabile, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04778.x · Cited by 68
Subcellular localization of α-synuclein in primary neuronal cultures: effect of missense mutations
McLean, P. J., Ribich, S. A., & Hyman, B. T. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6284-2_5 · Cited by 66
Kosten, J., Binolfi, A., Stuiver, M., Verzini, S., Theillet, F., Bekei, B., van Rossum, M., & Selenko, P. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002254 · Cited by 66
Interactions between metals and α‐synuclein − function or artefact?
Brown, D. R. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05917.x · Cited by 64
Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
Amschl, D., Neddens, J., Havas, D., Flunkert, S., Rabl, R., Römer, H., Rockenstein, E. M., Masliah, E., Windisch, M., & Hutter‐Paier, B. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-6 · Cited by 64
Phosphorylation-dependent metal binding by α-synuclein peptide fragments
Liu, L. L., & Franz, K. J. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0181-y · Cited by 62
Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
Oueslati, A., Ximerakis, M., & Vekrellis, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.324 · Cited by 59
Self-citationHara, S., Arawaka, S., Sato, H., Machiya, Y., Cui, C., Sasaki, A., Koyama, S., & Kato, T. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0903 · Cited by 56
Febbraro, F., Şahin, G., Farran, A., Soares, S., Jensen, P. H., Kirik, D., & Romero‐Ramos, M. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.014 · Cited by 56
Localization of CKII β subunits in Lewy bodies of Parkinson's disease
Ryu, M., Kim, D. W., Arima, K., Mouradian, M. M., Kim, S. U., & Lee, G. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.027 · Cited by 54
Bergeron, M., Motter, R. N., Tanaka, P., Fauss, D., Babcock, M., Chiou, S.-S., Nelson, S., Pablo, F. S., & Anderson, J. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.061 · Cited by 51
Li, J., Ma, W., Wang, P., Hurley, P. J., Bunz, F., & Hwang, P. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.022 · Cited by 48
Dissecting the Mechanisms of Tissue Transglutaminase-induced Cross-linking of α-Synuclein
Schmid, A. W., Chiappe, D., Pignat, V., Grimminger, V., Hang, I., Moniatte, M., & Lashuel, H. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809067200 · Cited by 48
Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease
Pouclet, H., Lebouvier, T., Coron, E., Neunlist, M., & Derkinderen, P. (2012) · Movement Disorders · doi:10.1002/mds.24993 · Cited by 46
Phosphorylated α‐synuclein in normal mouse brain
Hirai, Y., Fujita, S. C., Iwatsubo, T., & Hasegawa, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.046 · Cited by 45
Role of Ser129 phosphorylation of α-synuclein in melanoma cells
Lee, B. R., Matsuo, Y., Cashikar, A. G., & Kamitani, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.122093 · Cited by 45
Two Different Binding Modes of α-Synuclein to Lipid Vesicles Depending on its Aggregation State
Högen, T., Levin, J., Schmidt, F., Caruana, M., Vassallo, N., Kretzschmar, H. A., Bötzel, K., Kamp, F., & Giese, A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.01.059 · Cited by 44
Determining nuclear localization of alpha-synuclein in mouse brains
Huang, Z., Xu, Z., Wu, Y., & Zhou, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.016 · Cited by 44
Lrrk2 interaction with α-synuclein in diffuse Lewy body disease
Qing, H., Zhang, Y., Deng, Y., McGeer, E. G., & McGeer, P. L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.126 · Cited by 36
Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants
Salvi, M., Trashi, E., Marin, O., Negro, A., Sarno, S., & Pinna, L. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.152 · Cited by 32
Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
Nübling, G., Levin, J., Bader, B., Lorenzl, S., Hillmer, A. S., Högen, T., Kamp, F., & Giese, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098906 · Cited by 32
Fiske, M., Valtierra, S., Solvang, K., Zorniak, M., White, M., Herrera, S., Konnikova, A., Brezinsky, R., & DebBurman, S. K. (2011) · Parkinson s Disease · doi:10.4061/2011/392180 · Cited by 32
Cited by
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Rey, N. L., Steiner, J. A., Maroof, N., Luk, K. C., Madaj, Z., Trojanowski, J. Q., Lee, V. M.-Y., & Brundin, P. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160368 · Cited by 388
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Borgo, C., D’Amore, C., Sarno, S., Salvi, M., & Ruzzene, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00567-7 · Cited by 362
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Masato, A., Plotegher, N., Boassa, D., & Bubacco, L. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0332-6 · Cited by 328
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Fields, C. R., Bengoa-Vergniory, N., & Wade-Martins, R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00299 · Cited by 328
Metadata
- Authors
- Oueslati, A.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-03-11
- Volume
- 6
- Issue
- 1
- Pages
- 39-51
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W2310305711
- Cited by
- 375
- References
- 129
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.